Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Jović Zlatović, Josipa"'
Autor:
Dedić Plavetić, Natalija, Dugonjić Okroša, Ana, Silovski, Tajana, Jović Zlatović, Josipa, Jajac Bručić, Lana, Skelin, Marko, Mucalo, Iva
Adding ovarian function suppression to adjuvant endocrine therapy (AET) lowers the disease recurrence rates among premenopausal women with hormone receptor-positive (HR+) early breast cancer (EBC). However, a detrimental effect on endocrine symptoms
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=57a035e5b1ae::576e725feeebe51065895f7947b4306d
https://www.bib.irb.hr/1277251
https://www.bib.irb.hr/1277251
Publikováno v:
Libri Oncologici : Croatian Journal of Oncology
Volume 49
Issue 2-3
Libri Oncologici, Vol 49, Iss 2-3, Pp 76-79 (2021)
Volume 49
Issue 2-3
Libri Oncologici, Vol 49, Iss 2-3, Pp 76-79 (2021)
In randomized clinical trials, trifluridine / tipiracil (TT) demonstrated beneficial effects on progression-free survival (PFS) and overall survival (OS) in patients with refractory metastatic colorectal cancer (mCRC). The aim of this unicentric stud
Autor:
Ladenhauser, Tatjana, Golčić, Marin, Urch, Kristina, Budisavljević, Anuška, Simetić, Luka, Kovač Peić, Anamarija, Dilber, Ivo, Antunac Golubić, Zrna, Blažičević, Krešo, Curić, Zvonimir, Nalbani, Mario, Belić, Dino, Radmilović Varga, Ljubica, Mirčevski, K, Jović Zlatović, Josipa, Kocić, Lidija, Pleština, Stjepko
Terapija imunim checkpoint inhibitorima (ICI) odobrena je od strane Hrvatskog zavoda za zdravstveno osiguranje (HZZO) godine 2017. te se od tada oni koriste za sve više malignih sijela. Unatoč velikim stečenim iskustvima u primjeni, do sada još n
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=57a035e5b1ae::8a36fe41ffbbcd06430261c286c6dab7
https://www.bib.irb.hr/1237001
https://www.bib.irb.hr/1237001
Autor:
Belac Lovasić, Ingrid, Bašić Koretić, Martina, Podolski, Paula, Dedić Plavetić, Natalija, Silovski, Tajana, Pleština, Stjepko, Jazvić, Marijana, Soldić, Željko, Šeparović, Robert, Tečić Vuger, Ana, Beketić Orešković, Lidija, Tomaš, Ilijan, Flam, Josipa, Petrić Miše, Branka, Ban, Marija, Telesmanić Dobrić, Vesna, Budisavljević, Anuška, Jović Zlatović, Josipa, Nalbani, Marijo, Vojnović, Željko, Marušić, Zlatko, Tomić, Snježana, Avirović, Manuela, Štambuk, Bojan, Vrdoljak, Danko Velimir, Prutki, Maja, Brkljačić, Boris, Tadić, Tade, Mijatović, Davor, Stanec, Zdenko, Milas, Ivan, Vrdoljak, Eduard
Publikováno v:
Liječnički vjesnik
Volume 144
Issue 9-10
Volume 144
Issue 9-10
Rak dojke je najčešći zloćudni tumor u žena koji se može probirom, redovitim kontrolama i zdravstvenim odgojem otkriti u ranim stadijima bolesti i uspješno liječiti. Metode liječenja uključuju kirurgiju, kemoterapiju, radioterapiju, endokri
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::8dbd0981fe58865eecc7604f4ae6e622
https://urn.nsk.hr/urn:nbn:hr:105:977208
https://urn.nsk.hr/urn:nbn:hr:105:977208
Autor:
Jović Zlatović, Josipa, Grubišić-Čabo, Filip, Jajac Bručić, Lana, Skelin, Marko, Budisavljević, Anuška, Telesmanić Dobrić, Vesna, Zubčić Krišto, Slavica, Bilić Knežević, Sara, Curić, Zvonimir, Nalbani, Mario, Vojnović, Željko, Kelemenić- Dražin, Renata, Čonkaš, Mislav, Borić-Mikez, Zvjezdana, Kovač Peić, Anamarija, Opačić, Duška, August, Davor, Kardum Fucak, Iva
Uvod: Kombinacija CDK4/6 inhibitora i endokrine terapije (ET) produžuje preživljenje kod bolesnica s metastatskim hormonski ovisnim HER2 negativnim rakom dojke uz prihvatljiv sigurnosni profil. Od kolovoza 2018.godine primjena inhibitora CDK4/6 pos
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=57a035e5b1ae::51547a784d3cce4809ecee82cfd7b216
https://www.bib.irb.hr/1164551
https://www.bib.irb.hr/1164551
Autor:
Marijanović, Inga, Kraljević, Marija, Jović Zlatović, Josipa, Buhovac, Teo, Pavleković, Gordana
Publikováno v:
Psychiatria Danubina
Volume 32
Issue suppl. 4
Volume 32
Issue suppl. 4
Background: To analyse the early stage breast cancer tumour size distribution as an important prognostic factor among the female patients within our local geographic region of Herzegovina. Subjects and methods: This cross-sectional retrospective stud
Autor:
Omrčen, Tomislav, Boraska Jelavić, Tihana, Šitum, Marijan, Vilović, Katarina, Dolić, Krešimir, Zahirović, Dag, Pavlović Ružić, Ira, Krpina, Kristian, Jazvić, Marijana, Ružić, Boris, Ulamec, Monika, Gamulin, Marija, Gnjidić, Milena, Kaštelan, Željko, Ćorić, Marijana, Alduk, Ana Marija, Drežnjak Madunić, Maja, Jović Zlatović, Josipa, Curić, Zvonimir, Vrdoljak, Eduard
Publikováno v:
Liječnički vjesnik
Volume 141
Issue 11-12
Volume 141
Issue 11-12
Svjetlostanični karcinom bubrežnih stanica najčešći je oblik raka bubrega. Klinički je uglavnom asimptomatski, a samo se kod manjeg postotka bolesnika očituje hematurijom, tupom boli i palpabilnom masom u trbuhu. Najčešće se otkrije slučaj
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::eebaa51d28501502f4511eae210ddd5a
https://www.bib.irb.hr/1048231
https://www.bib.irb.hr/1048231
Palijativna skrb je pristup koji poboljšava kvalitetu života bolesnika i njihovih obitelji suočenih s problemima neizlječivih, uznapredovalih bolesti, putem sprječavanja i ublažavanja patnje pomoću ranog prepoznavanja i besprijekorne prosudbe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=57a035e5b1ae::c37fe3ff6f9ea6ca7ba2596e5482e9ab
https://www.bib.irb.hr/1041679
https://www.bib.irb.hr/1041679
Autor:
Vrdoljak, Eduard, Bošković, Lidija, Gašparić, Maja, Belac Lovasić, Ingrid, Soldić, Željko, Petrić Miše, Branka, Jazvić, Marijana, Božac Radolović, Liliana, Jović Zlatović, Josipa, Petković, Marija, Guguć, Damir
Investigation to adherence to AI, vitamin D and calcium in postmenopausal women with early breast cancer in Croatia
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=57a035e5b1ae::ea99aac6412b33a81d7373177717a909
https://www.bib.irb.hr/1088646
https://www.bib.irb.hr/1088646
Autor:
Karadža-Lapić L; Department of Otorhinolaryngology, General Hospital Šibenik, Šibenik, Croatia. ljerka.karadzalapic@gmail.com., Pikivaca T; University of Zagreb, School of Medicine Zagreb, Zagreb, Croatia; Public Health Centre Zagreb, Zagreb, Croatia., Pervan P; University of Zagreb, School of Medicine Zagreb, Zagreb, Croatia; Public Health Centre Zagreb, Zagreb, Croatia., Jović Zlatović J; Department of Internal Medicine, General Hospital Šibenik, Šibenik, Croatia., Delin S; Department of Pediatric, General Hospital Zadar, Zadar, Croatia., Prkačin I; University of Zagreb, School of Medicine Zagreb, Zagreb, Croatia; Clinical Hospital Merkur, Department of Internal Medicine/Emergency Unit, Zagreb, Croatia.
Publikováno v:
Acta medica academica [Acta Med Acad] 2018 May; Vol. 47 (1), pp. 11-17.